-+ 0.00%
-+ 0.00%
-+ 0.00%

Upgrade of revenue and operating profit guidance

Barchart·10/05/2026 03:48:00
Listen to the news

ANNOUNCEMENT NO. 317
5 October 2026


ChemoMetec maintained its positive momentum in the first quarter of the 2026/27 financial year, supported by higher-than-expected demand for our instruments, with the NC-203 being a key driver, including a lower-than-expected cost base.

Read more at globenewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.